BLBD Q1 2026 Earnings EPS Surpasses Estimates by Nearly 11 Amid Positive Market Response ADMA Biologics Q1 2026 Earnings EPS Miss Weighs on Shares as Profitability Path Remains in Focus Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares CNC Q1 2026 Earnings Robust EPS Surprise Drives Stock Higher UTZ Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower on Mixed Sentiment NE Q1 2026 Earnings EPS Beats Estimates by 301 Stock Declines